1.Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital.
Jae Hoon KIM ; Ju Seung KIM ; Jong Joon LEE ; Jung Ho KIM ; Suk Young KIM ; Young Kul JUNG ; Oh Sang KWON ; Yun Soo KIM ; Duck Joo CHOI ; Ju Hyun KIM
The Korean Journal of Internal Medicine 2014;29(3):307-314
BACKGROUND/AIMS: The Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention in South Korea have been organizing hepatitis B virus (HBV) vertical infection prevention projects since July 2002. In this single-institute study, the results of surveys conducted in target mothers who delivered babies in a tertiary hospital were investigated and analyzed. METHODS: Of the 9,281 mothers and their 9,824 neonates born between July 2002 and December 2012, 308 hepatitis B surface antigen (HBsAg)-positive mothers and their 319 neonates were selected for this study, and their records were analyzed retrospectively. RESULTS: A total of 308 mothers were HBsAg-positive, with an HBV prevalence of 3.32% (308/9,281). There were 319 neonates born to these HBsAg-positive mothers, and 252 were confirmed to as either HBsAg-positive or -negative. Four were confirmed as HBsAg-positive, with a 1.59% (4/252) HBV vertical infection rate. All the mothers of neonates who had an HBV vertical infection were hepatitis B e antigen (HBeAg)-positive. Among the HBsAg-positive neonates, three were HBeAg-positive and had an HBV DNA titer of 1.0 x 10(8) copies/mL. CONCLUSIONS: The HBV prevalence of mothers was 3.32% (308/9,281), and their vertical infection rate was 1.59% (4/252). Thus, the South Korean HBV vertical infection prevention projects are effective, and, accordingly, HBV prevalence in South Korea is expected to decrease continuously.
Adult
;
Biological Markers/blood
;
DNA, Viral/blood
;
Female
;
Health Surveys
;
Hepatitis B/blood/diagnosis/epidemiology/prevention & control/*transmission/virology
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B e Antigens/blood
;
Hepatitis B virus/genetics/immunology
;
Humans
;
Infant, Newborn
;
*Infectious Disease Transmission, Vertical/prevention & control
;
*National Health Programs
;
Pregnancy
;
Prevalence
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
*Tertiary Care Centers
;
Viral Load
2.Recent trends in hepatitis B virus infection in the general Korean population.
Hyuck KIM ; A Ri SHIN ; Hoe Hoon CHUNG ; Min Kyoung KIM ; Ji Sung LEE ; Jae Jun SHIM ; Byung Ho KIM
The Korean Journal of Internal Medicine 2013;28(4):413-419
BACKGROUND/AIMS: Hepatitis B virus (HBV) is the major cause of chronic liver disease in Korea, but viral prevalence has decreased because of hepatitis B vaccination programs. In this study, we investigated longitudinal changes in HBV in fection in the general Korean population. METHODS: HBV surface antigen (hepatitis B surface antigen, HBsAg) seropositivity was assessed from the Korea National Health and Nutrition Examination Survey (I to V). In total, 50,140 subjects were tested for serum HBsAg positivity over a period of 12 years (1998 to 2010). RESULTS: The prevalence of HBsAg seropositivity decreased over the study period. The rates of HBsAg carriers were 4.61% in 1998, 4.60% in 2001, 3.69% in 2005, 3.01% in 2008, and 2.98% in 2010 (p < 0.0001). The reduction in HBV infection rates was more prominent in younger age groups. Among teenagers (10 to 19 years), the percentage of HBsAg carriers decreased from 2.2% in 1998 to 0.12% in 2010 (p < 0.0001). Among those aged 10 to 39 years, the percentage of HBV infection decreased from 4.72% in 1998 to 2.29% in 2010 (p < 0.0001). However, no decreasing trend in HBsAg positivity was observed among those aged 50 or older (p > 0.05). Neither gender nor socioeconomic status were associated with the decreased prevalence of HBsAg carriers. CONCLUSIONS: HBV infection has decreased in the Korean population since the advent of vaccination programs. However, the decrease is limited to the younger population, and viral persistence remains in the middle-aged and older population.
Adolescent
;
Adult
;
Age Distribution
;
Age Factors
;
Aged
;
Biological Markers/blood
;
Chi-Square Distribution
;
Child
;
Cross-Sectional Studies
;
Female
;
Health Surveys
;
Hepatitis B/diagnosis/*epidemiology/prevention & control
;
Hepatitis B Surface Antigens/blood
;
Hepatitis B Vaccines/therapeutic use
;
Humans
;
Longitudinal Studies
;
Male
;
Middle Aged
;
Prevalence
;
Republic of Korea/epidemiology
;
Seroepidemiologic Studies
;
Socioeconomic Factors
;
Time Factors
;
Young Adult